Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Autosomal dominant Charcot-Marie-Tooth disease type 2Q is a rare subtype of autosomal dominant Charcot-Marie-Tooth disease type 2 characterized by adolescent to adulthood-onset of symmetrical, slowly progressive distal muscle weakness and atrophy (with a predominant weakness of the distal lower limbs) associated with reduced or absent deep tendon reflexes, pes cavus and mild to moderated deep sensory impairment.
Features include always present findings: Skeletal muscle atrophy, Hyporeflexia, Distal lower limb muscle weakness, and Pes cavus and others; and very common findings: Impaired distal vibration sensation. 7 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Muscles | 2 | Skeletal muscle atrophy, Distal lower limb muscle weakness |
Brain and nerves | 2 | Hyporeflexia, Difficulty walking (gait disturbance) |
Bones and joints | 1 | Skeletal muscle atrophy |
Arms and legs | 1 | Distal lower limb muscle weakness |
DHTKD1 encodes dehydrogenase E1 and transketolase domain containing 1 (919 aa). 2-oxoadipate dehydrogenase (E1a) component of the 2-oxoadipate dehydrogenase complex (OADHC). Highest expression in Liver (51.2 TPM) and Cells EBV-transformed lymphocytes (43.7 TPM).
Charcot-Marie-Tooth disease axonal type 2Q is associated with mutations in the DHTKD1 gene on chromosome 10.
DHTKD1 is classified as a druggable target (Enzyme category) with score 0.0.
Genetic testing for DHTKD1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 5 always present features, 1 very common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 7:58 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Charcot-Marie-Tooth disease axonal type 2Q